Department of Radiology, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL, USA.
Clin Radiol. 2013 Dec;68(12):e707-14. doi: 10.1016/j.crad.2013.07.012. Epub 2013 Aug 26.
Urolithiasis is a common disease with a reported prevalence between 4% and 20% in developed countries. Determination of urinary calculi composition is a key factor in preoperative evaluation, treatment, and stone recurrence prevention. Prior to the introduction of dual-energy computed tomography (DECT), available methods for determining urinary stone composition were only available after stone extraction, and thereby unable to aid in optimized stone management prior to intervention. DECT utilizes the attenuation difference produced by two different x-ray energy spectra to quantify urinary calculi composition as uric acid or non-uric acid (with likely further classification in the future) while still providing the information attained with a conventional CT. Knowledge of DECT imaging pitfalls and stone mimics is important, as the added benefit of dual-energy analysis is the determination of stone composition, which in turn affects all aspects of stone management. This review briefly describes DECT principles, scanner types and acquisition protocols for the evaluation of urinary calculi as they relate to imaging pitfalls (inconsistent characterization of small stones, small dual-energy field of view, and mischaracterization from surrounding material) and stone mimics (drainage devices) that may adversely impact clinical decisions. We utilize our clinical experience from scanning over 1200 patients with this new imaging technique to present clinically relevant examples of imaging pitfalls and possible mechanisms for resolution.
尿路结石是一种常见疾病,在发达国家的患病率为 4%至 20%。尿石成分的确定是术前评估、治疗和预防结石复发的关键因素。在双能计算机断层扫描(DECT)问世之前,确定尿石成分的可用方法仅在结石取出后才能获得,因此无法在干预前帮助优化结石管理。DECT 利用两种不同 X 射线能谱产生的衰减差异来定量尿石成分,如尿酸或非尿酸(未来可能有进一步分类),同时仍提供常规 CT 获得的信息。了解 DECT 成像的陷阱和结石模拟是很重要的,因为双能分析的附加益处是确定结石成分,这反过来又影响结石管理的各个方面。本文简要描述了 DECT 原理、扫描仪类型和采集方案,用于评估尿路结石,以及与成像陷阱(小结石特征不一致、小双能视野和周围材料误判)和结石模拟物(引流装置)相关的成像陷阱,这些可能会对临床决策产生不利影响。我们利用我们在 1200 多名患者中使用这种新成像技术的临床经验,提出了成像陷阱和可能解决方法的临床相关实例。